NCT02126384
Identifocation the B Cell Subsets Responsible for Anti-pneumococcal Response basic_science Not Available completed NCT01810861
Serotype Distribution of Streptococcus Pneumoniae That Causes Invasive Diseases at Children and Adults in Turkey No drug interventions Not Available Not Available completed NCT06182124
A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults prevention 1 / 2 active_not_recruiting NCT06524414
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants prevention 2 recruiting NCT06531538
A Study to Learn About How a New Pneumococcal Vaccine Works in Children prevention 2 recruiting NCT05512819
A Study to Describe the Safety and Immunogenicity of 20vPnC in Infants in India and Taiwan No drug interventions prevention 3 active_not_recruiting NCT06622109
A Study to Learn About the Safety of PREVENAR 20 Vaccine in Infants Aged Between Two to Six Months No drug interventions Not Available Not Available not_yet_recruiting NCT05633992
Safety and Immunogenicity of V116 in Vaccine-naïve Japanese Older Adults (V116-009, STRIDE-9) prevention 3 completed NCT04633226
Safety and Immunogenicity of V114 in Healthy Infants in South Korea (V114-036) prevention 3 completed NCT05408429
Safety and Immunogenicity of 20vPnC in Toddlers With 2 Prior Doses of Prevenar 13 No drug interventions prevention 3 completed NCT05464420
A Study to Evaluate the Safety, Tolerability, Immunogenicity, and Lot Consistency of V116 in Adults 18 to 49 Years of Age (V116-004, STRIDE-4) prevention 3 completed NCT03803202
A Single Ascending Dose Study in Adults (Stage 1) and Single Ascending Dose-Finding Study (Stage 2) in Elderly Subjects With ASP3772, A Pneumococcal Vaccine prevention 1 / 2 completed NCT01767402
Study to Evaluate Safety, Reactogenicity and Immunogenicity of the Pneumococcal Protein PhtD Vaccine in Healthy Adults prevention 1 completed NCT04875533
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Pneumococcal Vaccine-Naïve Adults 60 Years of Age and Older in Japan, Korea, and Taiwan prevention 3 completed NCT06044077
A Clinical Trial to Evaluate the Immunogenicity and Safety of the 23-valent Pneumococcal Polysaccharide Vaccine in Healthy People No drug interventions prevention 3 recruiting NCT05489328
Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age No drug interventions prevention 1 completed NCT05393037
Safety and Immunogenicity of V116 in Adults Living With Human Immunodeficiency Virus (HIV) (V116-007, STRIDE-7) prevention 3 completed NCT00743652
Study Evaluating the Impact of the 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Alaskan Native Children. No drug interventions prevention 3 completed NCT05329259
A Study to Describe the Safety of a Vaccine (Called 13vPnC) in Healthy People 18 to 49 Years of Age in India No drug interventions prevention 4 completed NCT00757575
Disease Burden of Pneumonia, Meningitis and Bacteremia Among Children in Japan: Pneumonet Japan No drug interventions Not Available Not Available completed NCT03835975
Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal Vaccination No drug interventions prevention 3 completed NCT00471770
Pneumoniae Epidemiology Study in China No drug interventions Not Available Not Available completed NCT04525599
A Study to Assess the Safety, Tolerability and Immunogenicity of ASP3772, a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Comparison to an Active Comparator prevention 1 completed NCT01396434
Safety Surveillance of Pneumococcal 13-valent Conjugate Vaccine Among Filipinos Not Available Not Available completed NCT05831124
A Study to Learn About a Type of Pneumococcal Vaccine With a New Ingredient (PF-07872411) Intended to Enhance the Effects of the Vaccine Which is Given to Adults No drug interventions prevention 1 completed NCT01896596
Hepatitis B Vaccination in Infants prevention 4 completed NCT04830358
Safety and Immunogenicity of the 'EuPCV15' in Healthy Korean Adults No drug interventions prevention 1 completed NCT01834222
Post Market Surveillance to Observe Safety of Prevenar13™ in Adults No drug interventions Not Available Not Available completed NCT06026748
A Phase I Study of XJ103 in Chinese Healthy Subjects No drug interventions treatment 1 active_not_recruiting NCT02146365
Nasopharyngeal Carriage Study in Healthy Kenyan Toddlers No drug interventions Not Available Not Available completed NCT04526574
Safety and Immunogenicity of 20vPnC Coadministered With SIIV in Adults ≥65 Years of Age No drug interventions prevention 3 completed NCT00234338
Study Evaluating Prevenar in High-Risk Children No drug interventions Not Available Not Available completed NCT04530838
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study in Healthy Japanese Infants No drug interventions prevention 3 completed NCT01040143
A Study to Assess the Impact of Pneumococcal Conjugate Vaccination Programme on the Carriage of Pneumococci No drug interventions Not Available Not Available completed NCT04642079
Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age No drug interventions prevention 3 completed NCT05569954
Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults 50 Years of Age or Older (V116-010, STRIDE-10) prevention 3 active_not_recruiting NCT01095471
13 Valent Pneumococcal Conjugate Vaccine - Follow-on Study No drug interventions prevention 4 completed NCT01564771
Serotype Distribution of Chest X-ray Confirmed Pneumococcal Community Acquired Pneumonia in the Adult Population in Greece, Over 1 Year. No drug interventions Not Available Not Available completed NCT04379713
20-valent Pneumococcal Conjugate Vaccine Safety Study in Healthy Infants No drug interventions prevention 3 completed NCT03828617
Trial to Evaluate the Safety and Immunogenicity of 3 Lots of 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults No drug interventions prevention 3 completed NCT01432158
Pneumococcal Adult Kinetics Study - Understanding the B Cell Response to Pneumococcal Vaccines prevention 3 completed NCT01734239
A Phase III Clinical Trial to Study the Safety and Immunogenicity of Pneumovax™ 23 (V110) in Participants From the Russian Population (V110-018) prevention 3 completed NCT04546425
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 3-Dose Series in Healthy Infants No drug interventions prevention 3 completed NCT04887948
Safety and Immunogenicity Study of 20vPnC When Coadministered With a Booster Dose of BNT162b2 prevention 3 completed NCT04382326
20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants No drug interventions prevention 3 completed NCT01128426
Postlicensure Observational Safety Study of 13vPnC Administered to Infants and Toddlers No drug interventions Not Available Not Available completed NCT05875727
A Study to Learn About the Safety and Immune Response of 20vPnC in Adults in India. No drug interventions prevention 3 completed NCT01298544
A Study to Assess the Antibody Response of Healthy Chinese Children Who Have Been Vaccinated Previously With 4-doses of Prevenar (a Pneumococcal Vaccine) as Babies and Toddlers No drug interventions prevention 4 completed NCT02308540
Safety and Immunogenicity of a 10 Valent Pneumococcal Conjugate Vaccine (SIILPCV10) in Healthy Adults, Toddlers, Infants prevention 1 / 2 completed NCT03760146
Trial to Evaluate the Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-naïve Adults prevention 3 completed NCT00843895
Multicenter Prospective Evaluation of the Incidence and Serotyes of Invasive Pneumoccocal Disease (IPD) Among Children Below 5 Years No drug interventions screening Not Available unknown_status NCT01111214
Child Pneumococcal Serotype Epidemiology In Greece No drug interventions Not Available Not Available completed